Pacini, M.F.; Bulfoni Balbi, C.; Dinatale, B.; Farré, C.; Cacik, P.; Gonzalez, F.B.; Marcipar, I.; Pérez, A.R.
Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model. Vaccines 2024, 12, 1171.
https://doi.org/10.3390/vaccines12101171
AMA Style
Pacini MF, Bulfoni Balbi C, Dinatale B, Farré C, Cacik P, Gonzalez FB, Marcipar I, Pérez AR.
Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model. Vaccines. 2024; 12(10):1171.
https://doi.org/10.3390/vaccines12101171
Chicago/Turabian Style
Pacini, Maria Florencia, Camila Bulfoni Balbi, Brenda Dinatale, Cecilia Farré, Paula Cacik, Florencia Belén Gonzalez, Iván Marcipar, and Ana Rosa Pérez.
2024. "Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model" Vaccines 12, no. 10: 1171.
https://doi.org/10.3390/vaccines12101171
APA Style
Pacini, M. F., Bulfoni Balbi, C., Dinatale, B., Farré, C., Cacik, P., Gonzalez, F. B., Marcipar, I., & Pérez, A. R.
(2024). Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model. Vaccines, 12(10), 1171.
https://doi.org/10.3390/vaccines12101171